Synthesis, Biological Evaluation and Molecular Docking Studies of Bis-Chalcone Derivatives as Xanthine Oxidase Inhibitors and Anticancer Agents
dc.contributor.author | Burmaoğlu, Serdar | |
dc.contributor.author | Özcan, Şeyda | |
dc.contributor.author | Balcıoğlu, Sevgi | |
dc.contributor.author | Gencel, Melis | |
dc.contributor.author | Noma, Samir Abbas Ali | |
dc.contributor.author | Eşsiz, Şebnem | |
dc.contributor.author | Ateş, Burhan | |
dc.contributor.author | Algül, Öztekin | |
dc.date.accessioned | 2020-10-07T11:30:20Z | en_US |
dc.date.available | 2020-10-07T11:30:20Z | en_US |
dc.date.issued | 2019 | en_US |
dc.department | Fakülteler, Mühendislik ve Doğa Bilimleri Fakültesi, Biyoinformatik ve Genetik Bölümü | en_US |
dc.description.abstract | In this study, a series of B-ring fluoro substituted bis-chalcone derivatives were synthesized by Claisen-Schmidt condensation reactions and evaluated for their ability to inhibit xanthine oxidase (XO) and growth inhibitory activity against MCF-7 and Caco-2 human cancer cell lines, in vitro. According to the results obtained, the bis-chalcone with fluoro group at the 2 (4b) or 2,5-position (4g) of B-ring were found to be potent inhibitors of the enzyme with IC50 values in the low micromolar range. The effects of these compounds were about 7 fold higher than allopurinol. The binding modes of the bis-chalcone derivatives in the active site of xanthine oxidase were explained using molecular docking calculations. Also, compound 4g and 4h showed in vitro growth inhibitory activity against a panel of two human cancer cell lines 1.9 and 6.8 μM of IC50 values, respectively. | en_US |
dc.identifier.citation | 42 | |
dc.identifier.doi | 10.1016/j.bioorg.2019.103149 | en_US |
dc.identifier.issue | 10/01/19 | en_US |
dc.identifier.pmid | 31382060 | en_US |
dc.identifier.scopus | 2-s2.0-85071831143 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12469/3470 | |
dc.identifier.uri | https://doi.org/10.1016/j.bioorg.2019.103149 | |
dc.identifier.volume | 91 | en_US |
dc.identifier.wos | WOS:000487812000046 | en_US |
dc.institutionauthor | Gencel, Melis | en_US |
dc.institutionauthor | Eşsiz, Şebnem | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.journal | Bioorganic Chemistry | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | Bis-chalcone | en_US |
dc.subject | Claisen-Schmidt condensation | en_US |
dc.subject | Cytotoxicity | en_US |
dc.subject | Inhibition | en_US |
dc.subject | Synthesis | en_US |
dc.title | Synthesis, Biological Evaluation and Molecular Docking Studies of Bis-Chalcone Derivatives as Xanthine Oxidase Inhibitors and Anticancer Agents | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | a83da4e2-c934-413a-886f-2438d0a3fd58 | |
relation.isAuthorOfPublication.latestForDiscovery | a83da4e2-c934-413a-886f-2438d0a3fd58 |